SCHEMBL18540569

SCHEMBL18540569

CC(=O)CSc1nnc(-c2cccc(C(=O)O)c2)[nH]1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.45
RAB9A P51151 2/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
KDM4E B2RXH2 1/20 0.45
ALDH1A1 P00352 1/20 0.45
HPGD P15428 1/20 0.45
GRK6 P43250 1/20 0.45
ADORA2B P29275 1/20 0.41
KMO O15229 2/20 0.41
ACMSD Q8TDX5 3/20 0.41
CD74 P04233 1/20 0.40
MIF P14174 1/20 0.40
APEX1 P27695 1/20 0.40
LMNA P02545 1/20 0.39
GAA P10253 1/20 0.39
MEN1 O00255 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18540519 0.91 GRK6 (0.51) SMN1; SMN2GRK6LMNAMEN1KMT2A
SCHEMBL14907836 0.90 APEX1 (0.51) NPC1RAB9ASMN1; SMN2KDM4EALDH1A1
SCHEMBL18540535 0.85 SMN1; SMN2 (0.49) NPC1RAB9ASMN1; SMN2ALDH1A1HPGD
SCHEMBL14907821 0.85 GRK6 (0.62) SMN1; SMN2KDM4EALDH1A1GRK6APEX1
SCHEMBL16171163 0.85 GRK6 (0.48) NPC1RAB9ASMN1; SMN2KDM4EALDH1A1
SCHEMBL18540514 0.84 GRK6 (0.47) NPC1RAB9ASMN1; SMN2ALDH1A1GRK6
SCHEMBL16171090 0.83 GRK6 (0.51) KDM4EALDH1A1GRK6APEX1KMT2A
SCHEMBL18540518 0.81 GRK6 (0.51) NPC1RAB9ASMN1; SMN2KDM4EALDH1A1
SCHEMBL16171093 0.81 GRK6 (0.48) KDM4EALDH1A1GRK6APEX1KMT2A
SCHEMBL18540507 0.81 GRK6 (0.50) SMN1; SMN2ALDH1A1GRK6MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170050939-A1 SMALL MOLECULE INHIBITORS OF G PROTEIN COUPLED RECEPTOR 6 KINASE POLYPEPTIDES MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) 2017-02-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170050939-A1 SMALL MOLECULE INHIBITORS OF G PROTEIN COUPLED RECEPTOR 6 KINASE POLYPEPTIDES GRK6, GRK2, GRK3 NPC1 4476/4885RAB9A 1688/4885SMN1; SMN2 4578/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.